ProQR Therapeutics (PRQR) EBT Margin Growth (5y) (2018 - 2026)
ProQR Therapeutics (PRQR) EBT Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55,409.00 |
| Dec 31, 2025 | -10,075.00 |
| Sep 30, 2025 | -26,115.00 |
| Jun 30, 2025 | -19,630.00 |
| Mar 31, 2025 | -13,369.00 |
| Dec 31, 2024 | -10,981.00 |
| Sep 30, 2024 | -12,032.00 |
| Jun 30, 2024 | 5,272.00 |
| Mar 31, 2024 | -7,537.00 |
| Dec 31, 2023 | -10,607.00 |
| Sep 30, 2023 | -29,736.00 |
| Jun 30, 2023 | -56,899.00 |
| Mar 31, 2023 | -135,191.00 |
| Dec 31, 2022 | -195,269.00 |
| Sep 30, 2022 | -285,442.00 |
| Jun 30, 2022 | -133,600.00 |
| Mar 31, 2022 | -135,407.00 |
| Dec 31, 2021 | -753,661.00 |
| Sep 30, 2021 | -162,151.00 |
| Jun 30, 2021 | -636,724.00 |